1 – 15 of 15
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy
(
- Contribution to journal › Article
- 2018
-
Mark
Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia
(
- Contribution to journal › Article
- 2017
-
Mark
Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Assessing the value of cancer treatments from real world data-Issues, empirical examples and lessons learnt
(
- Contribution to journal › Article
-
Mark
Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34+CD38- stem and progenitor cells in chronic myeloid leukemia
(
- Contribution to journal › Article
- 2016
-
Mark
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli
(
- Contribution to journal › Article
- 2015
-
Mark
Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib
(
- Contribution to journal › Article
-
Mark
Chronic myeloid leukemia
2015) p.153-174(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Functional Modeling of Genes Upregulated in Chronic Myeloid Leukemia
(
- Thesis › Doctoral thesis (compilation)
- 2011
-
Mark
A Multicellular Basis for the Origination of Blast Crisis in Chronic Myeloid Leukemia
(
- Contribution to journal › Article
- 2007
-
Mark
Cytogenetic evolution patterns in CML post-SCT.
(
- Contribution to journal › Article
-
Mark
Computational biology of blood disorders: Patterns and algorithms
2007) In Lund University Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Molecular and functional studies of the BCR/ABL1 fusion gene
2006)(
- Thesis › Doctoral thesis (compilation)
- 2004
-
Mark
Characterization of Genetic Abnormalities at Disease Progression of Chronic Myeloid Leukemia
2004)(
- Thesis › Doctoral thesis (compilation)
- 1996
-
Mark
Molecular Genetic Studies of Ph-positive Leukemias and the BCR and ABL Genes
1996)(
- Thesis › Doctoral thesis (compilation)